Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

SberMarket has launched catering delivery in St. Petersburg

3/4/24 SBER

Yandex.Market launched its own brand of pet products Lapsville

3/4/24 YNDX

Rusagro reports for 2023

3/4/24 RAGR

Debts of energy sales companies can be paid by consumers

3/4/24 FEES

Gazprom sells assets in the North Sea

3/4/24 GAZP

VTB reported for 2023 by RAS

3/1/24 VTBR

Nizhnekamskshina reported for 2023 by RAS

3/1/24 NKSH

Mosenergo reported for 2023 by RAS

3/1/24 MSNG

Segezha Group opened a new plywood delivery route to China

3/1/24 SGZH

Unipro reported for 2023 by RAS

3/1/24 UPRO